NCT01719055 RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain
| NCT ID | NCT01719055 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Scientific Corporation |
| Condition | Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,800 participants |
| Start Date | 2012-11-19 |
| Primary Completion | 2035-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,800 participants in total. It began in 2012-11-19 with a primary completion date of 2035-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To compile characteristics of real-world clinical outcomes for Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice, when used according to the applicable Instructions for Use \- and - To evaluate the economic value and technical performance of Boston Scientific commercially approved neurostimulation systems for pain in routine clinical practice
Eligibility Criteria
Key Inclusion Criteria: * Study candidate is scheduled to be trialed, on-label, with a commercially approved Boston Scientific neurostimulation system for pain, per local directions for use * Signed a valid, IRB/EC-approved informed consent form * 18 years of age or older Key Exclusion Criteria: * Contraindicated for Boston Scientific neurostimulation system * Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments
Contact & Investigator
Natalie Bloom Lyons
STUDY DIRECTOR
Boston Scientific Corporation
Frequently Asked Questions
Who can join the NCT01719055 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01719055 currently recruiting?
Yes, NCT01719055 is actively recruiting participants. Contact the research team at BSNClinicalTrials@bsci.com for enrollment information.
Where is the NCT01719055 trial being conducted?
This trial is being conducted at Phoenix, United States, Phoenix, United States, Tucson, United States, Campbell, United States and 11 additional locations.
Who is sponsoring the NCT01719055 clinical trial?
NCT01719055 is sponsored by Boston Scientific Corporation. The principal investigator is Natalie Bloom Lyons at Boston Scientific Corporation. The trial plans to enroll 4,800 participants.